Issued Patents All Time
Showing 1–25 of 71 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415779 | Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof | Charles Cook, Jiping Fu, Yigang He, Rongzhen Chen, Yan Dong | 2025-09-16 |
| 12410190 | Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases | Yi-Cheng Chen | 2025-09-09 |
| 12391642 | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors | Jiping Fu, Yigang He | 2025-08-19 |
| 12331026 | Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors | — | 2025-06-17 |
| 12312370 | Immunoproteasome inhibitors | Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein | 2025-05-27 |
| 12264167 | Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors | Jiping Fu, Yigang He | 2025-04-01 |
| 12171741 | 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors | Jiping Fu, Yigang He | 2024-12-24 |
| 12077506 | Indane derivatives as hypoxia inducible factor-2(α) inhibitors | Jiping Fu, Yigang He | 2024-09-03 |
| 12024531 | Immunoproteasome inhibitors | Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein | 2024-07-02 |
| 11993610 | BCL-2 inhibitors | Yi-Cheng Chen | 2024-05-28 |
| 11827656 | Immunoproteasome inhibitors | Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein | 2023-11-28 |
| 11753366 | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors | Jiping Fu, Yigang He | 2023-09-12 |
| 11680072 | Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases | Yi-Cheng Chen | 2023-06-20 |
| 11634382 | Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile | Jiping Fu, Yigang He, Yuetao SHI, Peng ZHOU, Xingxing LI | 2023-04-25 |
| 11518772 | Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors | Jiping Fu, Yigang He | 2022-12-06 |
| 11459340 | Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors | Jiping Fu, Yigang He | 2022-10-04 |
| 11420936 | Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases | Jiping Fu, Yigang He | 2022-08-23 |
| 11365206 | BCL-2 inhibitors | Yi-Cheng Chen | 2022-06-21 |
| 11279711 | Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases | Yi-Cheng Chen | 2022-03-22 |
| 11267782 | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors | Jiping Fu, Yigang He | 2022-03-08 |
| 11225493 | Immunoproteasome inhibitors | Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein | 2022-01-18 |
| 11154563 | Immunoproteasome inhibitors | Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein | 2021-10-26 |
| 11034705 | Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors | Jiping Fu, Yigang He | 2021-06-15 |
| 10894797 | Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors | Jiping Fu, Yigang He | 2021-01-19 |
| 10709712 | Biaryl amide compounds as kinase inhibitors | Robert John Aversa, Paul A. Barsanti, Matthew Burger, Michael Patrick Dillon, Alan Dipesa +13 more | 2020-07-14 |